Consulte al Mdico Veterinario
Injection-site reactions including pain and erythema occur in more than 1 in 10 patients and are listed as very common adverse effects in the Summary of Product Characteristics
Avoiding protein shakes with strong artificial flavours, excessive sweetness, or thick, creamy textures may also improve tolerance
Squire, P., et al., Factors associated with weight loss response to GLP-1 analogues for obesity treatment: a retrospective cohort analysis, BMJ Open , Jan
Sermorelin is a synthetic peptide that mimics growth hormonereleasing hormone, a substance naturally produced by the hypothalamus
The GLP-1 agonists market report provides insights around existing treatment practices in patients with Glucagon-like Peptide-1 (GLP-1) Agonists, approved (if any) and emerging Glucagon-like Peptide-1 (GLP-1) Agonists, market share of individual therapies, patient pool eligible for treatment with Glucagon-like Peptide-1 (GLP-1) Agonists, along with current and forecasted 7MM Glucagon-like Peptide-1 (GLP-1) Agonists market size from 2020-2034 by therapies and by indication
